These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 20053392

  • 1. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M, Shiragami C, Shiraga F, Kano M, Iida T.
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [Abstract] [Full Text] [Related]

  • 2. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
    Sakai T, Ohkuma Y, Kohno H, Hayashi T, Watanabe A, Tsuneoka H.
    Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F, Sawa M, Wakabayashi T, Sasamoto Y, Suzuki M, Tsujikawa M.
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation.
    Costagliola C, Romano MR, dell'Omo R, Cipollone U, Polisena P.
    Am J Ophthalmol; 2007 Sep; 144(3):449-51. PubMed ID: 17765426
    [Abstract] [Full Text] [Related]

  • 5. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
    Saito M, Shiragami C, Shiraga F, Nagayama D, Iida T.
    Am J Ophthalmol; 2008 Dec; 146(6):935-41.e1. PubMed ID: 18723139
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.
    Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L, Gabrieli CB.
    Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation.
    Parodi MB, Iacono P, Menchini F, Sheth S, Polini G, Pittino R, Bandello F.
    Acta Ophthalmol; 2013 May; 91(3):267-73. PubMed ID: 21951313
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
    Moon SW, Kim MS, Kim ES, Yu SY, Kwak HW.
    Ophthalmologica; 2011 May; 225(3):169-75. PubMed ID: 21273795
    [Abstract] [Full Text] [Related]

  • 9. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 10. Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
    Viola F, Mapelli C, Villani E, Tresca Carducci F, Vezzola D, Ratiglia R.
    Eye (Lond); 2010 Aug; 24(8):1344-51. PubMed ID: 20339389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
    Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA, Yannuzzi LA.
    Arch Ophthalmol; 2006 Apr; 124(4):487-92. PubMed ID: 16606873
    [Abstract] [Full Text] [Related]

  • 14. One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.
    Shirakata Y, Shiragami C, Yamashita A, Nitta E, Fujiwara A, Shiraga F.
    Jpn J Ophthalmol; 2012 Nov; 56(6):599-607. PubMed ID: 22990616
    [Abstract] [Full Text] [Related]

  • 15. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy.
    Mukai R, Kishi S, Sato T, Watanabe G, Matsumoto H.
    Ophthalmologica; 2010 Sep; 224(5):267-73. PubMed ID: 20185940
    [Abstract] [Full Text] [Related]

  • 18. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
    Liu Q, Hu Y, Yu H, Yuan L, Hu J, Atik A, Guan M, Li D, Li X, Tang S.
    Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sagong M, Lim S, Chang W.
    Am J Ophthalmol; 2012 May; 153(5):873-882.e2. PubMed ID: 22265146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.